BLUE Stock Summary and Trading Ideas (Bluebird Bio | NASDAQ:BLUE)

bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.

Bluebird Bio trades on the NASDAQ stock market under the symbol BLUE.

As of April 23, 2024, BLUE stock price climbed to $0.97 with 4,728,859 million shares trading.

BLUE has a beta of 1.84, meaning it tends to be more sensitive to market movements. BLUE has a correlation of 0.03 to the broad based SPY ETF.

BLUE has a market cap of $187.08 million. This is considered a Micro Cap stock.

In the last 3 years, BLUE stock traded as high as $35.59 and as low as $.88.

The top ETF exchange traded funds that BLUE belongs to (by Net Assets): VTI, IWM, VXF, IWN, IBB.

BLUE has underperformed the market in the last year with a price return of -71.7% while the SPY ETF gained +24.3%. BLUE has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -23.6% and -16.3%, respectively, while the SPY returned +4.9% and -2.5%, respectively.

BLUE support price is $.90 and resistance is $1.00 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BLUE stock will trade within this expected range on the day.